Community Perception of Covid-19 Consequences on Urban Transport

The results of a short survey about the consequences of Covid-19 on urban transport submitted by our Urban Transports Community, highlight the need to urgently develop low carbon emissions means of transportation in order to improve the quality of life in urban areas.


Which impact do you think the Covid emergency will have on the way people move in cities? This is the question that we asked our readers in a short survey. The results do not depict how people will actually move but it nonetheless provides an interesting overview of the perception of this  issue by the members of our community.

The Covid pandemic has hit hard Southern Europe, in particular Italy and Spain, changing considerably our lives, and consequently our mobility.

Public transport is, in the view of our experts, another victim of the Covid emergency: 65% of the those who answered the survey think that people, even after the end of the emergency, will use public transport significantly less than before. The issue now is how these “former passengers” of the public transport services will move in our cities.

Herds of private vehicles appear as the most likely heir of crowded buses leading, consequently, to traffic jams and increase in pollution. However, the results of the survey also suggest that walking and biking could increase significantly. One point is clear: the future of our cities will depend on the capacity of the policy makers in the post Covid phase to promote a low carbon way of transportation. Otherwise, cities invaded by cars and covered by smog could become our new reality.

Now, more than ever, the projects of our community are essential and play a significant role in fighting climate change and contributing to cleaner and safer cities. The results of the survey are presented in the table below:


Follow us

Twitter: @interreg_gosump

Facebook: Urban Transports Community - Interreg Med

Youtube: Urban Transports GoSump

LinkedIn: Urban Transports Community - Interreg Med

Newsletter: Subscribe here